Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Oct;33(10):2745–2751. doi: 10.1128/jcm.33.10.2745-2751.1995

Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.

R K Straubinger 1, Y F Chang 1, R H Jacobson 1, M J Appel 1
PMCID: PMC228567  PMID: 8567917

Abstract

Dogs were challenged with Borrelia burgdorferi by exposure to ticks, with or without prior protection from infection by recombinant OspA (rOspA) vaccination. Sera from these dogs were tested for their capability to inhibit the growth of B. burgdorferi in vitro. Bacterial growth was detected by a color change in the culture medium, and the optical density was measured with a spectrophotometer in microtiter plates. By growth inhibition, which was complement dependent, the color change was lacking after 5 days of incubation. Over a 1-year study, nonvaccinated dogs infected by exposure to ticks showed high antibody titers to B. burgdorferi by kinetic enzyme-linked immunosorbent assay (KELA). The same sera did not inhibit spirochetal growth or did so only at a low dilution. These results corresponded to the lack of OspA and OspB antibodies seen in Western blots (immunoblots), and these dogs were not protected from infection or disease. In contrast, dogs immunized with rOspA prior to challenge with infected ticks produced high antibody titers, as determined by KELA, but their sera also had high growth-inhibiting antibody titers. Western blot analysis showed a strong band in the 32-kDa region when the sera of these dogs were tested. When adjuvant was administered with rOspA, antibody titers by both KELA and growth inhibition were higher and persisted longer in the immunized dogs. All dogs immunized with rOspA were protected from infection and disease.

Full Text

The Full Text of this article is available as a PDF (302.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel M. J., Allan S., Jacobson R. H., Lauderdale T. L., Chang Y. F., Shin S. J., Thomford J. W., Todhunter R. J., Summers B. A. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis. 1993 Mar;167(3):651–664. doi: 10.1093/infdis/167.3.651. [DOI] [PubMed] [Google Scholar]
  2. Aydintug M. K., Gu Y., Philipp M. T. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun. 1994 Nov;62(11):4929–4937. doi: 10.1128/iai.62.11.4929-4937.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbour A. G. The diagnosis of Lyme disease: rewards and perils. Ann Intern Med. 1989 Apr 1;110(7):501–502. doi: 10.7326/0003-4819-110-7-501. [DOI] [PubMed] [Google Scholar]
  4. Burkot T. R., Piesman J., Wirtz R. A. Quantitation of the Borrelia burgdorferi outer surface protein A in Ixodes scapularis: fluctuations during the tick life cycle, doubling times, and loss while feeding. J Infect Dis. 1994 Oct;170(4):883–889. doi: 10.1093/infdis/170.4.883. [DOI] [PubMed] [Google Scholar]
  5. Callister S. M., Schell R. F., Case K. L., Lovrich S. D., Day S. P. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis. 1993 Jan;167(1):158–164. doi: 10.1093/infdis/167.1.158. [DOI] [PubMed] [Google Scholar]
  6. Callister S. M., Schell R. F., Lim L. C., Jobe D. A., Case K. L., Bryant G. L., Molling P. E. Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease. Arch Intern Med. 1994 Jul 25;154(14):1625–1632. [PubMed] [Google Scholar]
  7. Callister S. M., Schell R. F., Lovrich S. D. Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol. 1991 Sep;29(9):1773–1776. doi: 10.1128/jcm.29.9.1773-1776.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chang Y. F., Lauderdale T. L., Lee W. Y., Shin S. J., Jacobson R. H., Appel M. J., Lein D. H. Expression and secretion of outer surface protein (OSP-A) of Borrelia burgdorferi from Escherichia coli. FEMS Microbiol Lett. 1993 May 15;109(2-3):297–301. doi: 10.1016/0378-1097(93)90036-2. [DOI] [PubMed] [Google Scholar]
  9. Coleman J. L., Benach J. L. Characterization of antigenic determinants of Borrelia burgdorferi shared by other bacteria. J Infect Dis. 1992 Apr;165(4):658–666. doi: 10.1093/infdis/165.4.658. [DOI] [PubMed] [Google Scholar]
  10. Dattwyler R. J., Volkman D. J., Luft B. J., Halperin J. J., Thomas J., Golightly M. G. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988 Dec 1;319(22):1441–1446. doi: 10.1056/NEJM198812013192203. [DOI] [PubMed] [Google Scholar]
  11. Fikrig E., Barthold S. W., Flavell R. A. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun. 1993 Jun;61(6):2553–2557. doi: 10.1128/iai.61.6.2553-2557.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fikrig E., Bockenstedt L. K., Barthold S. W., Chen M., Tao H., Ali-Salaam P., Telford S. R., Flavell R. A. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis. 1994 Mar;169(3):568–574. doi: 10.1093/infdis/169.3.568. [DOI] [PubMed] [Google Scholar]
  13. Fikrig E., Huguenel E. D., Berland R., Rahn D. W., Hardin J. A., Flavell R. A. Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin. J Infect Dis. 1992 Jun;165(6):1127–1132. doi: 10.1093/infdis/165.6.1127. [DOI] [PubMed] [Google Scholar]
  14. Fikrig E., Telford S. R., 3rd, Barthold S. W., Kantor F. S., Spielman A., Flavell R. A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418–5421. doi: 10.1073/pnas.89.12.5418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gern L., Schaible U. E., Simon M. M. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis. 1993 Apr;167(4):971–975. doi: 10.1093/infdis/167.4.971. [DOI] [PubMed] [Google Scholar]
  16. Greene R. T., Walker R. L., Nicholson W. L., Heidner H. W., Levine J. F., Burgess E. C., Wyand M., Breitschwerdt E. B., Berkhoff H. A. Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs. J Clin Microbiol. 1988 Apr;26(4):648–653. doi: 10.1128/jcm.26.4.648-653.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hughes C. A., Engstrom S. M., Coleman L. A., Kodner C. B., Johnson R. C. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect Immun. 1993 Dec;61(12):5115–5122. doi: 10.1128/iai.61.12.5115-5122.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jobe D. A., Callister S. M., Lim L. C., Lovrich S. D., Schell R. F. Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi. J Clin Microbiol. 1994 Mar;32(3):618–622. doi: 10.1128/jcm.32.3.618-622.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kochi S. K., Johnson R. C., Dalmasso A. P. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J Immunol. 1991 Jun 1;146(11):3964–3970. [PubMed] [Google Scholar]
  20. Kochi S. K., Johnson R. C. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect Immun. 1988 Feb;56(2):314–321. doi: 10.1128/iai.56.2.314-321.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kornblatt A. N., Urband P. H., Steere A. C. Arthritis caused by Borrelia burgdorferi in dogs. J Am Vet Med Assoc. 1985 May 1;186(9):960–964. [PubMed] [Google Scholar]
  22. Lovrich S. D., Callister S. M., Lim L. C., DuChateau B. K., Schell R. F. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis. 1994 Jul;170(1):115–121. doi: 10.1093/infdis/170.1.115. [DOI] [PubMed] [Google Scholar]
  23. Lovrich S. D., Callister S. M., Schmitz J. L., Alder J. D., Schell R. F. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun. 1991 Aug;59(8):2522–2528. doi: 10.1128/iai.59.8.2522-2528.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ma J., Bulger P. A., Davis D. R., Perilli-Palmer B., Bedore D. A., Kensil C. R., Young E. M., Hung C. H., Seals J. R., Pavia C. S. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine. 1994 Aug;12(10):925–932. doi: 10.1016/0264-410x(94)90036-1. [DOI] [PubMed] [Google Scholar]
  25. Magnarelli L. A., Anderson J. F., Levine H. R., Levy S. A. Tick parasitism and antibodies to Borrelia burgdorferi in cats. J Am Vet Med Assoc. 1990 Jul 1;197(1):63–66. [PubMed] [Google Scholar]
  26. Nguyen T. P., Lam T. T., Barthold S. W., Telford S. R., 3rd, Flavell R. A., Fikrig E. Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun. 1994 May;62(5):2079–2084. doi: 10.1128/iai.62.5.2079-2084.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parker J. L., White K. K. Lyme borreliosis in cattle and horses: a review of the literature. Cornell Vet. 1992 Jul;82(3):253–274. [PubMed] [Google Scholar]
  28. Pavia C. S., Kissel V., Bittker S., Cabello F., Levine S. Antiborrelial activity of serum from rats injected with the Lyme disease spirochete. J Infect Dis. 1991 Mar;163(3):656–659. doi: 10.1093/infdis/163.3.656. [DOI] [PubMed] [Google Scholar]
  29. Preac-Mursic V., Wilske B., Patsouris E., Jauris S., Will G., Soutschek E., Rainhardt S., Lehnert G., Klockmann U., Mehraein P. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection. 1992 Nov-Dec;20(6):342–349. doi: 10.1007/BF01710681. [DOI] [PubMed] [Google Scholar]
  30. Ramachandra R. N., Wikel S. K. Modulation of host-immune responses by ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production. J Med Entomol. 1992 Sep;29(5):818–826. doi: 10.1093/jmedent/29.5.818. [DOI] [PubMed] [Google Scholar]
  31. Ribeiro J. M. Role of saliva in tick/host interactions. Exp Appl Acarol. 1989 Jun;7(1):15–20. doi: 10.1007/BF01200449. [DOI] [PubMed] [Google Scholar]
  32. Roehrig J. T., Piesman J., Hunt A. R., Keen M. G., Happ C. M., Johnson B. J. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol. 1992 Dec 1;149(11):3648–3653. [PubMed] [Google Scholar]
  33. Sadziene A., Jonsson M., Bergström S., Bright R. K., Kennedy R. C., Barbour A. G. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun. 1994 May;62(5):2037–2045. doi: 10.1128/iai.62.5.2037-2045.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sadziene A., Thompson P. A., Barbour A. G. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis. 1993 Jan;167(1):165–172. doi: 10.1093/infdis/167.1.165. [DOI] [PubMed] [Google Scholar]
  35. Sambri V., Armati S., Cevenini R. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement. FEMS Immunol Med Microbiol. 1993 Jun;7(1):67–71. doi: 10.1111/j.1574-695X.1993.tb00383.x. [DOI] [PubMed] [Google Scholar]
  36. Schaible U. E., Kramer M. D., Eichmann K., Modolell M., Museteanu C., Simon M. M. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci U S A. 1990 May;87(10):3768–3772. doi: 10.1073/pnas.87.10.3768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schmitz J. L., Schell R. F., Lovrich S. D., Callister S. M., Coe J. E. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun. 1991 Jun;59(6):1916–1921. doi: 10.1128/iai.59.6.1916-1921.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Schutzer S. E., Coyle P. K., Dunn J. J., Luft B. J., Brunner M. Early and specific antibody response to OspA in Lyme Disease. J Clin Invest. 1994 Jul;94(1):454–457. doi: 10.1172/JCI117346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Scriba M., Ebrahim J. S., Schlott T., Eiffert H. The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies. Infect Immun. 1993 Oct;61(10):4523–4526. doi: 10.1128/iai.61.10.4523-4526.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shih C. M., Telford S. R., 3rd, Spielman A. Effect of ambient temperature on competence of deer ticks as hosts for Lyme disease spirochetes. J Clin Microbiol. 1995 Apr;33(4):958–961. doi: 10.1128/jcm.33.4.958-961.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shin S. J., Chang Y. F., Jacobson R. H., Shaw E., Lauderdale T. L., Appel M. J., Lein D. H. Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs. Vet Microbiol. 1993 Jul;36(1-2):161–174. doi: 10.1016/0378-1135(93)90137-V. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Simon M. M., Schaible U. E., Wallich R., Kramer M. D. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immunol Today. 1991 Jan;12(1):11–16. doi: 10.1016/0167-5699(91)90106-4. [DOI] [PubMed] [Google Scholar]
  43. Szczepanski A., Benach J. L. Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol Rev. 1991 Mar;55(1):21–34. doi: 10.1128/mr.55.1.21-34.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Urioste S., Hall L. R., Telford S. R., 3rd, Titus R. G. Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism. J Exp Med. 1994 Sep 1;180(3):1077–1085. doi: 10.1084/jem.180.3.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES